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Abstract
The nature of the interaction of the transition-state analogue inhibitor l-leucinephosphonic acid (LPA) with the
leucine aminopeptidase from Aeromonas proteolytica (AAP) was investigated. LPA was shown to be a
competitive inhibitor at pH 8.0 with a Ki of 6.6 μM. Electronic absorption spectra, recorded at pH 7.5 of
[CoCo(AAP)], [CoZn(AAP)], and [ZnCo(AAP)] upon addition of LPA suggest that LPA interacts with both metal ions
in the dinuclear active site. EPR studies on the Co(II)-substituted forms of AAP revealed that the environments of
the Co(II) ions in both [CoZn(AAP)] and [ZnCo(AAP)] become highly asymmetric and constrained upon the
addition of LPA and clearly indicate that LPA interacts with both metal ions. The X-ray crystal structure of AAP
complexed with LPA was determined at 2.1 Å resolution. The X-ray crystallographic data indicate that LPA
interacts with both metal centers in the dinuclear active site of AAP and a single oxygen atom bridge is absent.
Thus, LPA binds to the dinuclear active site of AAP as an η-1,2-μ-phosphonate with one ligand to the second
metal ion provided by the N-terminal amine. A structural comparison of the binding of phosphonate-containing
transition-state analogues to the mono- and bimetallic peptidases provides insight into the requirement for the
second metal ion in bridged bimetallic peptidases. On the basis of the results obtained from the spectroscopic
and X-ray crystallographic data presented herein along with previously reported mechanistic data for AAP, a
new catalytic mechanism for the hydrolysis reaction catalyzed by AAP is proposed.

Dinuclear metallohydrolases catalyze the degradation of DNA, RNA, phospholipids, and polypetides and are,
consequently, key players in carcinogenesis, tissue repair, protein maturation, hormone regulation, cell-cycle
control, and protein degradation pathways (1−4). Examples of enzymes that fall into this class include
peptidases, amido- and amidinohydrolases, phosphatases, and nucleases. Therefore, these enzymes are of
immense industrial, environmental, and biomedical importance (5−7). Several dinuclear metallopeptidases
retain some catalytic activity as mononuclear enzymes but typically exhibit faster rates with dinuclear active
sites. The fact that some peptidases utilize a mononuclear center while others utilize either a mononuclear or
dinuclear site but still others require two metal ions to catalyze the same chemical reaction is not well
understood. Moreover, with the exception of copper, these enzymes utilize every first row transition metal ion
from manganese to zinc. Interestingly, the catalytic role of whatever metal ion is present in these enzymes
appears to be the same, i.e., to polarize the carbonyl group for nucleophilic attack, to activate a water molecule
to a more nucleophilic hydroxide ion, and/or to stabilize the transition state of the hydrolytic reaction. A
comparison of the one- and two-metal peptidases with known X-ray crystal structures reveals some features
common to both mono- and dinuclear enzymes (1, 8−10). All have at least one metal-bound water molecule,
and many have a nonmetal coordinating carboxylate residue, usually a glutamate that forms a hydrogen bond to
a metal-bond water molecule.

One of the best-characterized dinuclear metallopeptidases is the aminopeptidase from Aeromonas
proteolytica (AAP).1 AAP is a small, thermostable, monomeric enzyme (32 kDa) with a substrate preference for
hydrophobic N-terminal amino acid residues (11). The native enzyme as isolated requires two Zn(II) ions for full
activity; however, the enzyme is approximately 80% active with only one metal ion present. Substitution of the
two Zn(II) ions with Co(II), Cu(II), or Ni(II) provides an enzyme that is hyperactive by 7.7-, 6.5-, or 25-fold,
respectively, toward certain substrates (12−14). Bennett and Holz (15) recently demonstrated that metal binding
to apo-AAP occurs in a sequential fashion, highlighting the potential formation of heterodimetallic sites.
Catalytically competent heterodimetallic centers provide systems in which the function of each metal ion can be
independently studied by labeling the metal binding sites with spectroscopically active and silent metal ions. The
structure of native AAP was determined to 1.8 Å resolution (1AMP) and was shown to contain a single globular
domain with a centrally located mixed β-sheet sandwiched between α-helices (16). The dinuclear active site
contains a (μ-aquo)(μ-carboxylato)dizinc(II) core with a terminal carboxylate and histidine residue at each metal
ion, resulting in symmetric coordination spheres for the dinuclear cluster (Figure 1A). Both zinc ions reside in a
distorted tetrahedral coordination geometry with a Zn−Zn distance of 3.5 Å. A glutamate residue, Glu151, forms
a hydrogen bond with the bridging water molecule, while the second oxygen atom is 3.4 Å from Nε of His97
which is a ligand to Zn1.

Figure 1 (A) Schematic of the native AAP active site based on the coordinates of PDB entry 1AMP (16). The
dinuclear center is almost symmetric in that each zinc ion has a ligand donated by a terminal carboxylate and
histidine residue, in addition to the bridging aspartate and water molecule. Glu151, also shown, is not a metal
ligand but is thought to participate in the hydrolytic reaction. (B) Schematic of LPA bound to the dinuclear center
of blLAP, based on the coordinates of entry 1LCP (22). Bond distances are shown. The N-terminal amine of LPA
interacts with Zn2 of the binuclear cluster. A single oxygen atom acts as a bridge between the two metal ions. A
second phosphonate oxygen provides a ligand to Zn1. There is no residue equivalent to Glu151 of AAP in this
active site. (C) Schematic of the active site of the AAP−d-IPH complex based on the coordinates of
entry 1IGB (31). The hydroxylamino oxygen atom bridges the two zinc ions, and the keto group provides a ligand
to Zn1. The bridging water/hydroxyl molecule is no longer present. The amino-terminal nitrogen of d-IPH is
hydrogen bonded to the phenolic hydroxyl group of Tyr225.

Several inhibitors of AAP have been studied, and these molecules have recently been classified into three types:
substrate analogues, tetrahedral transition-state analogues, and simple metal-chelating agents. Examples of the
former two types include boronic acids (17−19), chloromethyl ketones (11), and phosphonic acids (20−22).
Among the metal chelators, hydroxamates (23−25) and α-hydroxyamides (11) have been shown to be
particularly potent inhibitors of AAP. In the phosphorus-containing transition-state analogue inhibitors, the
phosphorus atom is equivalent to the carbon atom that undergoes transformation from sp2 to sp3 hybridization
upon nucleophilic attack. For the one-metal peptidases, such as carboxypeptidase A and thermolysin, these
compounds are extremely tight binding competitive inhibitors (9−11). For example, a phophonate tripeptide
analogue inhibits carboxypeptidase A with a Ki of 11 fM (10, 12, 13), while a phophoamidate tripeptide analogue
inhibits thermolysin with a Ki of 68 pM (11). These same compounds inhibit dinuclear metallopeptidases with
significantly less potency. For example, l-leucinephosphonic acid (LPA) is a competitive inhibitor of the leucine
aminopeptidase from bovine lens (blLAP) with a Ki of 0.23 μM (22). The X-ray crystal structure of blLAP
complexed with LPA (22) shows that LPA interacts with both metal ions (Figure 1B) and suggests that both metal
ions are necessary to stabilize the transition state. In this structure, one phosphonate oxygen atom interacts
with Zn1, a second phosphonate oxygen atom bridges the two metal ions, and the N-terminal amine of LPA
interacts with Zn2. The two Zn(II) ions are 3.4 Å apart, which is 0.2 Å greater than the separation found in the
native structure. An X-ray crystal structure of AAP complexed with d-iodophenylalanine hydroxamate (d-IPH), a
simple metal-chelating agent, has also been determined (1IGB) (Figure 1C) (26). In this structure, two oxygen
atoms of d-IPH serve as ligands to the active site metal ions where the hydroxylamino oxygen atom bridges the
two zinc ions. The N-terminal amino group of d-IPH is hydrogen bonded to the phenolic oxygen of Tyr225.
However, the stereochemistry of d-IPH is incorrect since AAP only cleaves N-terminal l-amino acid residues,
decreasing the mechanistic relevance of the d-IPH−AAP complex.
In an effort to gain insight into the structure of the tetrahedral transition state of peptide hydrolysis, we have
explored the inhibition of AAP by l-leucinephosphonic acid (LPA). Analysis of the kinetic data for the interaction
of AAP with LPA at pH 8.0, the pH of maximal activity for AAP, shows that LPA is a strong competitive inhibitor.
Electronic absorption and EPR spectra of the catalytically competent [CoCo(AAP)], [CoZn(AAP)], and [ZnCo(AAP)]
substituted enzymes in the absence and presence of LPA provide insight into the mode of coordination of LPA to
AAP (21). The exact mode of LPA binding to AAP was elucidated by X-ray crystallographic determination of the
structure of the [ZnZn(AAP)]−LPA complex at 2.1 Å. Combination of the X-ray crystallographic and spectroscopic
data with the previously reported mechanistic data for AAP has allowed a detailed mechanism of action to be
proposed for the metal-mediated peptide hydrolysis reaction catalyzed by AAP.

Materials and Methods
Enzyme Purification.

All chemicals used in this study were purchased commercially and were of the highest quality available. LPA was
kindly provided by N. Sträter at Harvard University (Cambridge, MA). The aminopeptidase
from A.proteolytica was purified from a stock culture kindly provided by C. Schalk. Cultures were grown
according to the previously published procedure (11) with minor modifications to the growth media, the details
of which are presented elsewhere (27). Crude AAP is associated with two dark brown pigments that partition
between the enzyme and octyl-Sepharose column material to different extents. These pigments are only
completely removed from the enzyme during the ion exchange chromatography step. Both pigments have
intense electronic absorption in the 250−300 nm region. One of the pigments has an electronic absorption
maximum at 400 nm and gives rise to an intense isotropic EPR resonance at g = 4.3 indicative of it being
associated with Fe(III) (data not shown). The g = 4.3 EPR resonance can therefore be used as a sensitive test for

pigment removal. The purified enzyme used in this study was found not to exhibit the g = 4.3 EPR resonance.
Denaturing gel electrophoresis indicated that the two resolvable activity-containing fractions from the QSepharose column corresponded to the holoaminopeptidase and a processed form from which 13 N-terminal
amino acids have been cleaved [“AP1” and “AP2”, respectively in the nomenclature of Schalk et al. (28)]. The
enzyme was readily crystallized, a stringent test of homogeneity, and was shown to be identical to the structure
reported by Chevrier et al. (16). The enzyme was stored at 77 K until it was needed.

Spectrophotometric Assay.

AAP activity was measured by the method of Prescott and Wilkes (11) as modified by Baker et al. (18). In this
assay, the hydrolysis of 0.5 mM l-leucine p-nitroanilide (l-pNA) [10 mM Tricine (pH 8.0) containing 0.1 mM
ZnSO4 or CoCl2] was assessed spectrophotometrically at 25 °C by monitoring the formation of p-nitroaniline. The
extent of hydrolysis was calculated by monitoring the increase in absorbance at 405 nm (Δε405 value of pnitroaniline = 10 800 M-1 cm-1). One unit was defined as the amount of enzyme that releases 1 μmol of pnitroaniline at 25 °C in 60 s. Depletion of enzyme-bound zinc or cobalt was prevented by the addition of 0.1 mM
ZnSO4 or CoCl2 to the buffer. The specific activity of purified Zn(II)-bound AAP was typically found to be 120
units/mg of enzyme. This value is identical to that reported by Prescott and Wilkes (11). Enzyme concentrations
were determined from the absorbance at 280 nm with an ε280 of 41 800 M-1 cm-1 (29). The accuracy of this value
was checked by the Edelhoch method (30−32) using a 5:13:2 (molar ratio) N-acetyl-l-tryptophanamide/Gly-Tyramide/l-cysteine mixture to model AAP. The molar absorptivity determined from this method (ε280 = 43 950 M1
cm-1 for AAP solubilized in 6 M guanidine hydrochloride) was in excellent agreement with the value previously
reported by Prescott et al. (29).

Kinetic Studies.

The kinetic parameters v (velocity), kcat (Vmax/[E]o), Km (Michaelis constant), and Ki (inhibition constant) were
determined at pH 8.0 by spectrophotometrically recording the initial velocity of the hydrolysis of l-pNA at 25 °C
in triplicate for both the Zn(II) and Co(II) forms of AAP. LPA concentrations ranged from 0 to 17.5 μM, and
velocity values were recorded for each of seven substrate concentrations ranging from 5 to 200 μM. The
linearity of the progress curves for product formation both in the absence and in the presence of inhibitor
indicates that LAP is in rapid equilibrium with AAP. Depletion of enzyme-bound zinc was prevented by the
addition of 0.1 mM ZnSO4 or CoCl2 to all buffers. Because of the addition of excess divalent metal ions to the
assay mixture, there is no apoenzyme present. The apoenzyme would likely bind LPA but only very weakly. For
example, Ustynyuk et al. (33) has previously shown that l-leucine binds to AAP with a Ki of ∼1 mM, but this is
nearly 1000 times lower than the Ki value observed for LPA. Buffers used in the pH studies were Tricine (pH 7.5,
8.0, and 8.7) and boric acid (pH 9.0 and 9.5). The inhibitory nature of boric acid was investigated, and it was
found to be a weak competitive inhibitor (Ki ∼ 0.3 M). These data are in excellent agreement with the previous
results of Baker and Prescott (17).

EPR Samples.

[CoZn(AAP)] and [ZnCo(AAP)] were prepared from the purified enzyme by a method similar to that of Prescott et
al. (13). Briefly, AAP was dialyzed for 72 h at 4 °C against 10 mM 1,10-phenanthroline monohydrochloride in 50
mM Hepes buffer (pH 7.5) and then exhaustively dialyzed against Chelex-treated Hepes buffer. Metal insertion
was effected by direct addition, with efficient mixing, of 1 equiv of MCl2 (where M is Co or Zn; ≥99.999% CoCl2,
from Strem Chemicals, Newburyport, MA; 99.999% ZnCl2, from Aldrich) followed by a 30 min incubation period
at 20−25 °C. The second metal was then inserted in the same manner and the electronic absorption spectrum
recorded prior to freezing in liquid nitrogen for EPR spectroscopy. A 10-fold excess of LPA was introduced onto
the inside side wall of an EPR tube and the enzyme sample introduced above this as a plug ∼2 cm in length. As
earlier work has demonstrated by optical methods (34), violently flicking the above system facilitates rapid and

efficient mixing of the reagents and rapid freezing was achieved by plunging the tube into a beaker of a mixture
of liquid and solid methanol over liquid nitrogen.

Spectroscopic Measurements.

All spectrophotometric measurements were performed on a Shimadzu UV-3101PC spectrophotometer equipped
with a constant temperature holder and a Haake (type 423) constant temperature circulating bath. The use of
200 μL, 1 cm path length microcuvettes (QS, Hellma) stoppered with rubber septa facilitated the recording of
the optical spectra of EPR samples under anaerobic conditions. Subtraction of the absorption spectrum of apoAAP from those of the substituted enzymes was performed using Shimadzu UV-3101 software. Lowtemperature dual-mode EPR spectroscopy was performed using a Bruker ESP-300E spectrometer equipped with
an ER 4116 DM dual-mode X-band cavity and an Oxford Instruments ESR-900 helium flow cryostat as described
previously (15). Background spectra recorded on an EPR tube containing buffer were aligned with and
subtracted from experimental spectra as in earlier work (34). Characteristic signals due to oxygen were
occasionally observed in both EPR modes. These signals routinely disappeared upon increasing the temperature
in the helium cryostat to 125 K for 5 min and recooling. All spectra were recorded at a modulation frequency of
100 kHz and a modulation amplitude of 1.26 mT (12.6 G) and with a sweep rate of 10 mT/s. Parallel- and
perpendicular-mode EPR spectra were recorded at microwave frequencies of ∼9.37 and ∼9.65 GHz,
respectively: precise microwave frequencies were recorded for individual spectra to facilitate g alignment.
Other EPR recording parameters are specified in the figure legends for individual samples. Enzyme
concentrations for EPR were typically 1−2 mM. All buffers contained 20% 2-propanol to prevent aggregation at
high protein concentrations. The purified enzyme stored for up to 2 weeks at 4 °C in Hepes buffer (pH 7.5)
containing 20% (by volume) 2-propanol exhibited no measurable decrease in activity, and comparison of EPR
spectra with those recorded on more dilute samples in the absence of 2-propanol indicated that 2-propanol had
no effect on the electronic structure of the dinuclear metal center.

Computer Simulations of High-Spin Co(II) S = 3/2 EPR Spectra.

The protocol for simulation of high-spin Co(II) EPR spectra is described in detail elsewhere (15). This method of
analysis yields two sets of geff values: those obtained by simulation of the line shape and those allowed by
theory for an isotropic greal tensor. The latter values are given in parentheses after the former. Where an
isotropic greal value is assumed, the correspondence between these two sets of values is a quantitative indication
of the validity of the simulation. However, as pointed out by Johnson and co-workers (35), greal is often
anisotropic, lying in the range of 2.1−2.8, and an anisotropic greal value has to be assumed in some cases. In
these cases, the greal values that are given are those consistent with the three geff values and a single value
of E/D. In principle, information about the zero-field splitting parameter, Δ, can be obtained both from EPR
saturation behavior and from g values of Co(II) species. However, in practice this can prove to be both difficult
and misleading, and arguments against this approach have been outlined (15, 35). Furthermore, recent work has
demonstrated that for sites of nonideal geometry, as commonly found with protein metal binding centers, even
reliably determined zero-field splitting parameters are of little use in predicting the coordination of the metal
ion (36). Thus, no attempt to determine zero-field splitting parameters, other than E/D, was made.

Crystallization, Data Collection, and Processing.

AAP was cocrystallized with LPA using the crystallization conditions reported for the native enzyme (16),
following preincubation with a 4-fold molar excess of LPA. The inhibitor solution was prepared by titrating the
dissolved free acid with 1.0 M NaOH to neutrality before addition of the enzyme to avoid decreasing the pH
required for crystallization. The purified AAP (10 mg/mL) in 10 mM Tris (pH 8.0), 10 mM KSCN, 0.4 M NaCl, and a
4-fold molar excess of LPA was crystallized by vapor diffusion using 100 mM Tris (pH 8.0), 100 mM KSCN, and 4.5
M NaCl as the precipitating solution. Crystals with dimensions of 0.5 mm × 0.3 mm × 0.3 mm were obtained in 4

days and were shown to be isomorphous with the native crystals. The crystals belong to space group P6122 with
the following unit cell dimensions: a = b = 107.8 Å, c = 102.5 Å, α = β = 90°, and γ = 120°. There is one monomer
per asymmetric unit.
Diffraction data were collected at 4 °C on an R-axis IIC image plate area detector mounted on a Rigaku RU-200B
rotating anode generator operating at 45 kV and 120 mA. A 0.3 mm collimator was used, and the
crystal−detector distance was 100 mm. One crystal was used to collect the entire data set. Twenty-five minute
exposures were taken with an oscillation step size of 0.5°. The diffraction data were integrated and scaled using
the HKL software package (Denzo and Scalepack) (20). The data processing and refinement statistics are outlined
in Table 1. The data were collected with a high redundancy where 94.2% of the reflections were measured four
times or more and 29% of the observed reflections measured nine to twelve times. The overall completeness of
the data is 99.9%, including 100% completeness in the outermost shell (2.2−2.1 Å). The Rmerge in the outer shell
was 68.5%, resulting in an overall Rmerge of 18.1% for the entire data set. Ultimately, the decision to keep all of
the data to 2.1 Å was based on the quality of the electron density maps when these data were included.
Table 1: Data Collection and Refinement Statistics
Crystal Data
space group
P6122
unit cell parameters (Å)
a = 107.8, b = 107.8, c = 102.6
Data Processing
no. of observed reflections
349668
no. of unique reflections
21129
cutoff (I/σ)
0
Rmergea (outer shell) (%)
13.4
completeness, overall (%)
99.9
highest-resolution shell (Å)
2.17−2.1
completeness, outer shell (%)
100
Model Refinement
resoloution range (Å)
10−2.1
cutoff (F/σF)
0
b
R-factor (%)
19.8
Rfree (%)
23.2
no. of protein atoms
2211
no. of zinc ions
2
no. of LPA atoms
10
no. of water molecules
129
B-factor model
individual
rmsd from ideality
bond lengths (Å)
0.006
bond angles (deg)
1.153
improper angles (deg)
0.639
dihedral angles (deg)
25.931
c
residues in most favored positions (%)
86.4
a
Rmerge = ∑|Iobs − Iavg|/∑|Iavg|.b R-factor = ∑|Fobs − Fcalc|/∑|Fobs|.c As determined by the program PROCHECK.

Structure Solution and Refinement.

Since the crystal of the LPA-inhibited AAP was isomorphous with that of the native enzyme, the phases from the
published native structure (1AMP) were used as the starting model (16). In this process, the zinc atoms and

water molecules were omitted from the original coordinate file. All refinement procedures were carried out
using the software package X-PLOR(c) (21). An Rfree (22) data set was made using 10% of the unique reflections.
The initial model was subjected to two rigid body refinements, the first using reflections in the 12.0−6.0 Å range
and the second reflections in the 12.0−4.0 Å range. Subsequent rounds of positional refinement were carried
out using higher-resolution data incrementally to 2.1 Å. Difference electron density maps were then calculated
(3Fobs − 2Fcalc) (23, 24) and showed clear electron density in the active site for the bound inhibitor and the
missing zinc ions. The R-factor and Rfree at this point were 27 and 31%, respectively. The two zinc ions and
several obvious water molecules were added, and the model was subjected to further rounds of positional
refinement. The electron density maps calculated for the remainder of the refinement process were calculated
with 2Fobs − Fcalc and Fobs − Fcalc coefficients. A model for LPA was built using Insight (Molecular Simulations, Inc.),
and the model was built into the electron density. Additional water molecules were added to the model using
the WATERPICK protocol in the X-PLOR program. The electron density for one water molecule was larger than
that for the other water molecules, and the B-factor for this atom refined to an unusually low value of 2. In
addition, there were five atoms within 2.8 Å of this water molecule: one of the phosphoryl oxygens of the LPA
molecule (2.6 Å), two water molecules (2.2 and 2.4 Å), and one oxygen of the terminal carboxylate of Glu151
(2.6 Å). This atom was later modeled as a potassium ion and the B-factor then refined to 30 Å. Further rounds of
positional as well as both overall and individual B-factor refinement resulted in a final structure with an R-factor
and Rfree of 19.8 and 23.2%, respectively. In addition to the 291 amino acid residues, the final model contains 2
zinc ions, 129 water molecules, 1 potassium ion, and 10 atoms of the inhibitor molecule (Table 1). Simulated
annealing omit maps, in which the active site region was omitted, were calculated and confirmed the presence
of the bound inhibitor.

Results and Discussion
Despite their ubiquity and the wealth of structural information available for dinuclear hydrolytic enzymes, little
is known about how these structural motifs relate to function. Of the aminopeptidases, X-ray crystal structures
are available for the bovine lens leucine aminopeptidase (blLAP) (22, 37), the methionyl aminopeptidases
from Escherichia coli (38, 39), Pyrococcus furiosus (40), and Homo sapiens (41) (MetAP's), the aminopeptidase
from Streptomyces griseus (SAP) (42), and the aminopeptidase from A. proteolytica (AAP) (16). Previous kinetic,
spectroscopic, and crystallographic studies on aminopeptidases have focused primarily on the native enzyme
structure and that of the substrate-binding step of peptide hydrolysis (13, 15, 16, 26, 27, 33, 43, 44). Either
characterization of the transition state of AAP-catalyzed peptide hydrolysis has been limited to kinetic and
spectroscopic data, and an X-ray crystal structure of d-IPH bound to AAP (26). However, amino acid
hydroxamates are simple metal chelators and, therefore, do not represent the transition state of peptide
hydrolysis. To gain insight into the structure of the transition state of peptide hydrolysis, the inhibition of AAP by
LPA was examined by kinetic, spectroscopic, and X-ray crystallographic methods. A preliminary spectroscopic
study on the binding of LPA to AAP has been previously reported (21).

Kinetic Studies.

Initially, the rates of hydrolysis of l-pNA were monitored spectrophotometrically as a function of LPA
concentration in 10 mM Tricine buffer (pH 8.0) containing 0.1 mM ZnSO4 or CoCl2. Triplicate activity assay
determinations at five LPA concentrations (0−17.5 μM) were made for each of seven substrate concentrations
(5−200 μM). The linearity of the progress curves for product formation both in the absence and in the presence
of inhibitor indicates that LPA is in rapid equilibrium with AAP. The results for [ZnZn(AAP)] are shown in Figure
2 as a double-reciprocal plot of 1/v versus 1/[S], which shows a pattern indicative of competitive inhibition. The
experimental data were fit to the Michaelis−Menten equation for competitive inhibition reported by Cleland
(45). The Michaelis constant, Km, for l-pNA binding to AAP was found to be 10 μM, and the catalytic
constant, kcat, was found to be 4320 min-1. Both of these values are in excellent agreement with those previously

reported. Plots of 1/v and [S]/v versus [LPA] (data not shown) yield values for the inhibition constant, Ki, for the
binding of LPA to AAP of 6.6 ± 0.4 and 5.5 ± 0.4 μM for [ZnZn(AAP)] and [CoCo(AAP)], respectively. The intercept
of the plots of 1/v versus 1/[S] when 1/[S] = 0 (Figure 2) and the parallel plots of [S]/v versus [LPA] (data not
shown) clearly demonstrate that LPA is a pure competitive inhibitor of the hydrolysis of l-pNA by AAP (46). The
pH dependence of LPA binding to [ZnZn(AAP)] was also investigated at pH 9.5. The results indicate that the
mechanism of inhibition at pH 9.5 is also purely competitive with a Ki similar to that observed at pH 8.0. On the
basis of these data and the fact that LPA is a strong competitive inhibitor of blLAP with a Ki of 0.23 μM at pH 8.0
(22), LPA likely binds to AAP differently than blLAP.

Figure 2 Double-reciprocal plot of 1/v vs 1/[S]. The symbols correspond to LPA concentrations of 0, 2.5, 7.5, 12.5,
and 17.5 μM. Assays were carried out at 25 °C in 10 mM Tricine buffer (pH 8.0) containing 0.1 mM ZnSO4.

Spectroscopic Investigations.

To ascertain the nature of any geometrical change that might occur at the dinuclear active site of AAP upon LPA
binding, electronic absorption spectra of the catalytically competent [CoCo(AAP)], [CoZn(AAP)], and [ZnCo(AAP)]
forms were recorded in the absence and presence of LPA (21). The absorption due to apo-AAP was subtracted in
each case. The absorption spectrum of [CoCo(AAP)] (Figure 3) reveals an absorption maximum of 525 nm and a
molar absorptivity (ε) of ∼85 M-1 cm-1. The addition of LPA to [CoCo(AAP)] shifts the observed λmax from 525 to
500 nm with a concomitant increase in the absorption coefficient from 85 to 130 M-1 cm-1. Furthermore, the
electronic absorption spectrum of the [CoCo(AAP)]−LPA complex exhibits fine structure that is clearly resolved in
the first-derivative spectrum, dA/dλ versus λ (Figure 3, inset), as comprising five absorption bands at 488, 517,
549, 579, and 601 nm. The increase in the absorption coefficient and the appearance of fine structure are
indications that the geometry around one or both of the Co(II) ions is significantly altered upon LPA binding and
directly demonstrate interaction of LPA with the dinuclear catalytic metal center. The absorption spectra of
[CoZn(AAP)] (58 M-1 cm-1; Figure 4) and [ZnCo(AAP)] (29 M-1 cm-1; Figure 4) provide absorption coefficients that
are essentially the sum of the absorption coefficient of [CoCo(AAP)] (85 M-1 cm-1), indicating that the individual
Co(II) ions in [CoZn(AAP)] and [ZnCo(AAP)] adopt very similar coordination geometries in their respective
substituted enzyme forms as they do in the dinuclear center of [CoCo(AAP)]. Upon the addition of LPA to
[CoZn(AAP)], the λmax of 525 nm was not perturbed but the molar absorptivity increased from 58 to 68 M-1 cm1
(Figure 4). On the other hand, the addition of LPA to [ZnCo(AAP)] markedly affects the electronic absorption
spectrum as evidenced by the large increase in the absorption coefficient to 63 M-1 cm-1 (Figure 4) Interestingly,
the observed λmax exhibited the same characteristic blue shift as that of [CoCo(AAP)] from 525 to 500 nm. The
spectrum also exhibits the fine structure pattern that was also observed for LPA bound to [CoCo(AAP)]. These
data indicate that LPA interacts with both metal binding sites in AAP.

Figure 3 Electronic absorption spectrum of [CoCo(AAP)] in the absence (- - -) and presence (—) of 5 equiv of LPA.
The inset shows the electronic absorption spectrum of the [CoCo(AAP)]−LPA complex (- - -) and the first
derivative of the absorption, δA/δλ (—).

Figure 4 Electronic absorption spectra of [CoZn(AAP)] (−··−), [ZnCo(AAP)] (- - -), the [CoZn(AAP)]−LPA complex
(···), and the [ZnCo(AAP)]−LPA complex (—). The latter two samples contain 5 equiv of LPA.
EPR spectra of [CoCo(AAP)] in the absence and presence of LPA were also recorded in both the perpendicular
and parallel modes (Figure 5). In the absence of LPA, the perpendicular-mode EPR spectrum reveals an Ms =
|±1/2〉 ground-state transition with an isotropic greal of 2.25 and an E/D of 0.095, which accounts for only 13%
of the expected spin density, suggesting that the two Co(II) ions are spin-coupled, as previously reported (15).
The addition of LPA to [CoCo(AAP)] completely abolished the perpendicular-mode signal (21). These data
suggest that the spin coupling between the two Co(II) ions is markedly enhanced upon LPA binding and that LPA
must bind to both Co(II) ions. Examination of the [CoCo(AAP)]−LPA complex in the parallel mode revealed an
intense signal with a crossover point at g ∼ 10.3 at 9 K. This signal is likely due to ferromagnetic coupling
between two pseudo S = 1/2 Co(II) ions with large greal values (>2.5), yielding a pseudo S = 1 system. The
observation of ferromagnetic coupling between the two high-spin Co(II) ions suggests a spin−spin pathway
between the two metal centers. On the basis of the reported magnetic properties of several μ-aquo or (μhydroxo)dicobalt(II) model complexes, one would expect weak to moderately strong antiferromagnetic coupling
(47−49). Moreover, bis(μ-carboxylato)- and tetrakis(μ-carboxylato)dicobalt(II) cores also show very weak
antiferromagnetic spin coupling (50−52). These data suggest that a single oxygen atom bridge is not present in
the LPA−AAP complex and that the ferromagnetic spin-coupling interaction is not mediated through the
carboxylate bridge.

Figure 5 EPR spectra of [CoCo(AAP)]. (A) Perpendicular mode in the absence of LPA. (B) Parallel mode in the
absence of LPA. (C) Perpendicular mode in the presence of 5 equiv of LPA. (D) Parallel mode in the presence of 5
equiv of LPA. All samples were buffered with 50 mM Hepes (pH 7.5) containing 20% 2-propanol to prevent
aggregation. Perpendicular-mode spectra were recorded at 10 K with a microwave power of 0.2 mW, while
parallel-mode spectra were recorded at 3.9 K with a microwave power of 2 mW. All spectra were recorded using
a modulation amplitude of 1.26 mT and a sweep rate of 10 mT/s.
The EPR spectrum of [CoZn(AAP)] was also recorded and simulated as previously described (Figure 6A). Upon
addition of LPA to [CoZn(AAP)], a dramatic change in the EPR spectrum is observed. A rhombic, 59Co hyperfine
split species is observed that can be simulated as a single species with the parameters geff(x,y,z) = 1.90 (2.08), 3.05
(3.04), 6.66 (6.64) (the values given are those used for the line shape simulation, whereas those in parentheses
are the closest theoretically allowed values for an isotropic greal value; see Materials and Methods),
corresponding to an Ms = |±1/2〉 ground-state transition with an isotropic greal of 2.53 and an E/D of 0.26. While
EPR cannot give direct information regarding coordination geometries or coordination numbers of Co(II) ions, it
does provide information regarding electronic structure. From simulation of EPR spectra,
both E/D and greal values are readily obtained. Both of these parameters hold information regarding symmetry;
high greal values reflect extensive spin−orbit coupling, suggestive of low symmetry, and E/D (the rhombic
distortion on the axial ligand field) is a direct indication of the deviation from the idealized axial geometry of the
ion. Furthermore, anisotropy of greal can be taken as an indicator of the asymmetric distribution of the
paramagnetic electron density about the metal ion, reflecting any asymmetry in the electric field gradient across
the ion due to the ligand sphere.
For the [CoZn(AAP)]−LPA complex, agreement between the two highest geff values obtained from the line shape
simulation and by theory is excellent; however, agreement between the experimentally derived and
theoretically derived lowest geff value is poor. The three geff values, which are in good agreement with those
obtained by line shape simulation, correspond to a unique value for E/D but cannot be derived from theory for a
system with an isotropic greal value. These data suggest that greal is in fact anisotropic, and exact agreement
between experiment and theory for an E/D of 0.26 is obtained by assuming an axial greal with a gx of 2.31 and
a gy,z of 2.54. It should be noted that while these parameters represent a unique solution assuming gy = gz, many
solutions exist if one allows gx, gy, and gz to all differ. Nevertheless, the range of solutions that yield three
reasonable greal values is actually quite small. For example, assuming an E/D value of 0.2 yields gx, gy,
and gz values of 2.93, 2.82, and 2.36, respectively, of which gx and gy are unreasonably large. Similarly, assuming
an E/D value of 0.33 yields gx, gy, and gz values of 2.42, 2.06, and 2.55, respectively, of which gy is below the
usual lower limit (2.1) for Co(II) ions. Therefore, a reasonable estimate of the error in E/D for an anisotropic
system is ±0.04. The E/+D value for the [CoZn(AAP)]−LPA complex of 0.26, therefore, can only correspond to a

highly rhombically distorted axial zero-field splitting. Further support for this conclusion comes from the clearly
resolved 59Co hyperfine splitting and the similarity of the signal to the hyperfine split g = 2.54 signal observed in
[CoZn(AAP)] (Figure 6C). Simulation of the latter (Figure 6D) assumes an E/D of 0.32, and unlike the
[CoZn(AAP)]−LPA complex, a solution can be obtained assuming an isotropic greal value which is, therefore,
unique; consequently, the error in the estimation of E/D is very small (less than ±0.01). Thus, the g = 2.54 signal
of resting [CoZn(AAP)] certainly corresponds to a highly distorted electronic environment of the Co(II) ion. The
similarity of the EPR spectrum of the [CoZn(AAP)]−LPA complex is strong circumstantial evidence that it, too, is
of low symmetry. Further, the presence of resolved 59Co hyperfine splitting with both a similar line width
and Az(59Co) strongly suggests that the two species are correspondingly free of g strain and thus both are
geometrically highly constrained by the ligand field. Finally, the fact that the [CoZn(AAP)]−LPA complex is a
single species implies that unlike all the other mono-Co(II) signals observed for AAP thus far, the geometry must
be sufficiently constrained so as to preclude the appearance of the structural microheterogeneities which give
rise to the g strain, A strain, and E/D strain responsible for the presence of multiple species. Thus, it appears that
LPA binding locks the Co(II) ion in [CoZn(AAP)] into a very definite, defined coordination geometry, which must
be the result of direct ligation of the Co(II) ion by LPA.

Figure 6 EPR spectra of [CoZn(AAP)]. (A) In 50 mM Hepes buffer (pH 7.5) containing 20% 2-propanol. (B)
Simulation of spectrum A (—) assuming two species (- - -) with geff(x,y,z) = 2.20, 3.92, 5.23; Ms = |±1/2〉; greal =
2.29; and E/D = 0.10 and greal(xyz) = 1.80, 2.75, 6.88; Az(59Co) = 7.0 mT; Ms = |±1/2〉; greal = 2.54; and E/D = 0.32.
(C) In 50 mM Hepes buffer (pH 7.5) after the addition of 5 equiv of LPA. (D) Simulation of spectrum C
assuming geff(x,y,z) = 1.90, 3.05, 6.66; Az(59Co) = 7.0 mT; Ms = |±1/2〉; greal(x,y,z) = 2.31, 2.54, 2.54; and E/D = 0.26. All
spectra were recorded at 10 K and 0.2 mW, with a modulation amplitude of 1.26 mT and a sweep rate of 10
mT/s.
The EPR spectrum of [ZnCo(AAP)] is shown in Figure 7 and has been described in earlier work (15). Upon
addition of LPA to [ZnCo(AAP)], a dramatic change in the EPR spectrum is observed (21). The spectrum and a
computer simulation are presented in panels B and C of Figure 7, respectively. The simulation invoked a single
species with geff values of 6.23, 3.40, and 1.95 and an Az(59Co) of 4.95 mT. These values correspond to an
axial greal value where gx,y = 2.204, which gives rise to the resonance at geff = 1.95 and gz = 2.48. The rhombic
distortion of the axial field E/D = 0.20. This value is somewhat lower than that for the Co(II) ion in [CoZn(AAP)].
Interestingly, the 59Co hyperfine splitting is significantly smaller than that observed for other Co(II)-substituted
AAP species, and suggests delocalization of some 30% of the paramagnetic electron density from the cobalt
nucleus. This implies a direct interaction of the Co(II) ion with an electrophilic moiety such as the Nterminal amine group of LPA as was observed for LPA binding to blLAP by X-ray crystallography (22).
Delocalization of electron density onto a ligand atom orbital is also consistent with the anisotropy of greal for this

species. These data suggest that electron density donation by the second metal may be important in stabilizing
the transition state and thus suggests a role for the second metal ion in catalysis.

Figure 7 EPR spectrum of [ZnCo(AAP)] (A) in 50 mM Hepes buffer (pH 7.5) containing 20% 2-propanol and (B) in
the presence of 5 equiv of LPA. (C) Simulation of spectrum B assuming geff(x,y,z) = 6.23, 3.40, 1.95; Az(59Co) = 4.95
mT; Ms = |±1/2〉; greal(x,y,z) = 2.20, 2.20, 2.48; and E/D = 0.20. The experimental spectrum was recorded at 10 K
and 0.2 mW, with a modulation amplitude of 1.26 mT and a sweep rate of 10 mT/s.

X-ray Crystal Structure of the [ZnZn(AAP)]−LPA Complex.

While spectroscopic studies suggest that LPA binds to both metal ions of the dinuclear active site of AAP, the
only way to definitively determine the exact binding nature of LPA is by X-ray crystallography. Therefore, we
have crystallized AAP in the presence of LPA and have determined the X-ray crystal structure to 2.1 Å resolution
(Figure 8). Inhibitor binding does not introduce major conformation changes into the protein, and the structures
of the native AAP and AAP−LPA complex agree very well with an rms deviation of 0.21 Å for the 291 structurally
equivalent Cα atoms. The two Zn(II) atoms are 3.9 Å apart in the LPA complex (Figure 9) compared to 3.5 Å in
the native structure. This difference is significant at this resolution since the error in the coordinates is
approximately 0.3 Å. The leucine group of LPA resides in a well-defined hydrophobic pocket adjacent to the
dinuclear Zn(II) active sites. For AAP, this site is made up of Met180, Ile193, Cys223, Tyr225, Cys227, Met242,
Phe248, Tyr251, and Ile255. The two Cys residues form a disulfide bond at the back of this pocket, and on the
basis of previous X-ray crystallographic data as well as a recent kinetic study, this pocket was shown to be the
initial substrate recognition point on the enzyme (16, 26).

Figure 8 Stereoimage of the AAP−LPA complex active site. LPA binds to the binuclear center with one of the
ligands at Zn2 provided by the N-terminal amine and another by O3 of LPA. The LPA O1 atom provides a ligand
to Zn1. The bridging water/hydroxide molecule found in the native structure is not present in the AAP−LPA
complex.

Figure 9 Schematic of the active site in the AAP−LPA complex with distances (in angstroms) shown for all ligands
to the zinc ions. Some of the residues involved in van der Waals interactions with the side chain of the inhibitor
have been omitted for clarity.
The amino acid residues ligated to the dizinc(II) cluster are identical to those in the native structure with only
minor perturbations in the bond lengths (Table 2 and Figure 9). Zn1 of the [ZnZn(AAP)]−LPA complex resides in a
distorted tetrahedral environment, while Zn2 exhibits a distorted five-coordinate geometry. Glu152 is
coordinated in an asymmetric bidentate fashion to Zn1 with the additional oxygen atom providing a potential
fifth ligand at a distance of 2.4 Å. Similarly, Asp179 is coordinated to Zn2 in an asymmetric bidentate fashion
with the second oxygen atom residing 2.4 Å from the metal center, providing a potential sixth ligand. Two of the
LPA oxygen atoms are coordinated to the two Zn(II) ions in the active site. Namely, O1 is 1.9 Å from Zn1 and 3.4
Å from Zn2, while O3 is 3.3 Å from Zn1 and 2.3 Å from Zn2. There are no binding interactions between any single
atom of LPA and both zinc ions; the phosphonate oxygen atom, O3, is coordinated to Zn2, and O1 is coordinated
to Zn1. Moreover, there is no electron density between the two Zn(II) ions, suggesting that a bridging water
molecule does not exist. A hydrogen bond (3.0 Å) also exists between Glu151 and the O3 atom of the
phosphonate moiety. Since Glu151 forms a hydrogen bond with the bridging water/hydroxide molecule in the
native structure, the O3 atom of the phosphonate group likely represents the nucleophilic oxygen atom. Finally,
the NH2 group of LPA, which mimics the N-terminal amine group of an incoming peptide, is 2.1 Å from Zn2. The
X-ray crystallographic data indicate that LPA interacts with both metal centers and a single oxygen atom bridge
is absent. Thus, LPA binds to the dinuclear active site of AAP as an η-1,2-μ-phosphonate with one ligand to the
second metal ion provided by the N-terminal amine (Figure 9).
Table 2: Selected Bond Lengths (Å) for the Zinc−Ligand Distances in the AAP−LPA Complex
zinc−ligand
Zn1−Zn2
Zn1−Asp117 O2
Zn1−Glu152 O1
Zn1−Glu152 O2
Zn1−His256 N2
Zn1−H2O
Zn1−BuBA O1
Zn1−BuBA O2
Zn1−LPA O1
Zn2−Asp117 O1
Zn2−Asp179 O1
Zn2−Asp179 O2

zinc−ligand distance (Å)
native
3.5
2.1
2.0
2.4
2.3
2.3
−
−
−
2.0
2.1
2.3

BuBA complex
3.3
2.2
2.2
2.6
2.3
−
2.5
2.7
−
2.1
2.2
2.5

LPA complex
3.9
1.9
2.0
2.4
2.1
−
−
−
1.9
2.0
2.2
2.4

Zn2−His97 N2
Zn2−H2O
Zn2−BuBA O2
Zn2−BuBA O1
Zn2−LPA O3
Zn2−LPA NH2

2.3
2.3
−
−
−
−

2.2
−
3.0
4.4
−
−

2.2
−
−
−
2.3
2.1

According to the X-ray structure of the [ZnZn(blLAP)]−LPA complex (22), the transition-state analogue binds to
both metal ions through the PO3 moiety with a single oxygen atom of LPA bridging the dinuclear center (i.e., an
η-1-μ-phosphonate). This is distinctly different from the mode of binding of LPA to AAP, which does not have a
single oxygen atom bridge. However, both structures imply that the transition state of peptide hydrolysis is
stabilized by coordination of the gem-diol oxygen atoms to both metal ions and the N-terminal amine to one
metal ion [i.e., the peptide carbonyl group binds to one or both Zn(II) ions and the N-terminal amine binds to the
second Zn(II) ion]. Therefore, both metal ions are required for full enzymatic activity in both lbLAP and AAP, but
their individual roles in catalysis appear to differ even though both enzymes have nearly identical substrate
specificities.

Mechanistic Implications.

Combination of all of the reported kinetic, thermodynamic, spectroscopic, and X-ray crystallographic data
reported to date with the data presented herein has allowed a detailed mechanism of action to be proposed for
the peptide hydrolysis reaction catalyzed by AAP (Figure 10). On the basis of kinetic measurements of the level
of aliphatic alcohol binding to AAP, the incoming N-terminal peptide leucine group interacts with Phe244,
Phe248, Tyr251, and Tyr255 in the hydrophobic pocket adjacent to the dinuclear active site (33). This binding
scheme is consistent with the large negative entropy and large positive enthalpy of activation reported for AAP
(27). An active site carboxylate group, Glu151, was implicated in the catalytic process from X-ray crystallographic
data since Glu151 forms a hydrogen bond with the bridging water/hydroxide molecule in the resting enzyme
(16). We propose that the carbonyl oxygen atom of the incoming peptide binds to Zn1. This is consistent with
both EPR spectroscopic studies and the X-ray crystal structure of AAP in the presence of the substrate analogue
inhibitor BuBA which binds only to the first metal binding site (15, 43, 44). Bennett and Holz (15) recently
demonstrated that metal binding to apo-AAP occurs in a sequential fashion. It was also shown, on the basis of
electronic absorption and EPR spectroscopy, that the spectroscopic signatures for [Co_(AAP)] and [CoZn(AAP)]
were identical but distinct from those of [ZnCo(AAP)]. Combination of these data with the X-ray crystallographic
results of BuBA binding to AAP (44) indicates that the first metal binding site in AAP is the Zn1 site.

Figure 10 Proposed mechanism of peptide hydrolysis catalyzed by AAP. Protein ligands to the metal ions are
shown only in the first panel to avoid confusion. The orientation of this scheme is somewhat different from that
presented in Figure 9, because in the proposed mechanism, the substrate and the bridging water (hydroxide) are

bound simultaneously. If the mechanism were presented with the bound species in the same orientation as that
given in Figure 9, these groups would project on top of one another.
The fact that AAP exhibits 80% of its maximum activity with only a single Zn(II) ion bound and fluoride binding
occurs after substrate binding (27) suggests that the bridging water/hydroxide molecule becomes terminal upon
substrate binding and is bound to the Zn1 binding site. The breaking of the Zn2−OH(H) bond is likely assisted by
N-terminal amine binding which is corroborated by the observation that the N-terminal amine group (RNH2) of
LPA is coordinated to Zn2. Interestingly, the S atom of Met180, a residue in the hydrophobic pocket adjacent to
the dinuclear active site of AAP, is only 3.1 Å from the N-terminal amine group, suggesting a hydrogen bonding
interaction. Likewise, the O2 atom of Asp179 is 3.1 Å from the N atom of the N-terminal amine group, also
indicating a hydrogen bonding interaction. A similar interaction for the N-terminal amine of LPA has been shown
by X-ray crystallography for LPA bound to blLAP (22). Moreover, amine binding to the second Mn(II) ion in
arginase has been proposed to drive the loss of the bridging water/hydroxide molecule to form a terminal
hydroxide that functions as the nucleophile in the hydrolytic reaction (53). The breaking of the Zn2−OH(H) bond
is likely assisted by N-terminal amine binding as well as Asp99 hydrogen bonding to the Zn2 ligand, His97. The
role of Glu151 is likely to assist in the deprotonation of the terminal water molecule to the nucleophilic hydroxo
moiety, similar to that of Glu270 in carboxypeptidase A (37).
Recently, it was suggested that a combination of several hydrogen bonding interactions may act to destroy the
local symmetry of the dinuclear active site cluster as well as decrease the Lewis acidity of the Zn2 ion, thus
providing another driving force for breaking the Zn2−OH(H) bond (44). Breaking the Zn2−OH(H) bond would
leave the putative nucleophile (OH-) and the substrate on the same zinc (Zn1) ion. In this proposal, both the
substrate scissile carbonyl carbon and the nucleophile reside on the Zn1 site, thereby positioning a hydroxide for
nucleophilic attack. This proposal is consistent with the resent spectroscopic data and the X-ray crystal structure
of the substrate analogue inhibitor butaneboronic acid (BuBA) bound to AAP (15, 43, 44). The [ZnZn(AAP)]−LPA
X-ray crystal structure is also consistent with this suggestion in that one of these hydrogen bonding interactions
is between an oxygen atom of Glu151 and the coordinated Nε atom of His97, which is a ligand to Zn2. This
distance (3.2 Å) is somewhat shorter than the distance of 3.4 Å found in the native structure and allows for a
hydrogen bond between Glu151 and His97 that may not have existed in the native structure, or only existed
weakly or transiently. These data suggest that Glu151 may contribute to the regulation of the Lewis acidity of
Zn2. A second hydrogen bonding interaction is observed between Asp99 and His97, forming an Asp-His-Zn triad.
An oxygen atom of Asp99 is 2.9 Å from the Nδ atom of His97, suggesting a strong hydrogen bonding interaction.
This compares to a distance of 2.7 Å in the [ZnZn(AAP)]−BuBA structure and a distance of 2.8 Å in the resting
enzyme. Strong hydrogen bonds between active site Asp residues and histidine ligands in zinc metalloproteins
have been shown previously to provide a histidinate-like ligand (54), thus decreasing the Lewis acidity of Zn(II)
ions. For Zn2, coordination of Asp179 and Asp117 results in significant negative charge around the metal ion.
Therefore, the hydrogen bond between His97 and Asp99 provides some degree of a histidinate-like ligand,
which helps Zn2 modulate its Lewis acidity during catalysis and retain its charge neutrality. If this hydrogen bond
is sufficiently strong (the shortest distance occurs for the substrate-bound [ZnZn(AAP)]−BuBA structure), this
interaction can decrease the Lewis acidity of Zn2 sufficiently to assist in the loss of the bridging water/hydroxide
molecule.
Since AAP can function with only one metal ion present, the second metal ion must be replaced by another
active site group or groups when it is absent. For example, the MetAP from E. coli is fully active with only a single
Co(II) or Fe(II) ion present even though the available X-ray crystallographic data suggest a dinuclear active site
(55). The divalent metal binding nature of MetAP and AAP also appears to be analogous to those of the zincdependent β-lactamase from Bacillus cereus. Of the two Zn(II) ions in the active site of the β-lactamase from B.

cereus, the tightly bound Zn(II) ion is proposed to provide the nucleophile and also act as a Lewis acid to stabilize
the tetrahedral transition state (56, 57). The role of the second Zn(II) ion is unclear since a conserved
carboxylate residue is proposed to act as a general base to form the dianion and also to protonate the leaving
group, thus facilitating C−N bond cleavage. It has, therefore, been suggested that the B. cereus enzyme may be
an evolutionary intermediate between the mono- and dizinc(II) metallo-β-lactamases (58). Similarly, X-ray
crystallographic data for the MetAP from E. coli with a substrate analogue inhibitor bound (39) revealed that the
N-terminal amine nitrogen is coordinated to the noncatalytic Co(II) ion, which resides in the carboxylate only
side of the active site. For a single-metal ion mechanism to exist, it was recently proposed that the catalytic role
ascribed to the non-histidine-coordinated metal ion must be performed instead by the active site amino acid
group Asp97 and possibly Asp108 and Glu235. These carboxylate residues form a negatively charged pocket in
the appropriate position to bind the N-terminal amine moiety. A similar role for Asp179 and possibly Asp117 can
be envisioned for AAP when only one Zn(II) ion is bound. Thus, the second metal binding site in AAP plays a
catalytic role similar to that of the second metal ion in MetAP by interacting with the N-terminal amine;
however, in the absence of a divalent metal ion, the negatively charged carboxylate pocket interacts with the Nterminus, while in the presence of Zn(II), the divalent metal ion binds the N-terminal amine.
The position of the N-terminal amine group in LPA is distinctly different from that observed for the
[ZnZn(AAP)]−d-IPH complex (26). In the d-IPH complex, the N-terminal amine group is not present in the active
site pocket but instead forms a hydrogen bond with Tyr225 near the surface of the enzyme at the mouth of the
active site pocket. Conversely, the N-terminal amine in the LPA complex is coordinated to Zn2. Therefore, the
conformation of the inhibitor observed in the AAP−d-IPH complex is an inaccurate representation of the actual
transition state of peptide hydrolysis; i.e., the stereochemistry of the d-IPH inhibitor is incorrect for an actual
peptide since IPH resides in the d-configuration. With this in mind, little mechanistic information can be gleaned
from the [ZnZn(AAP)]−d-IPH structure since d-IPH is simply acting as a metal chelator, rather than mimicking
either substrate binding or the transition state of the catalytic reaction. Consequently, any mechanistic
conclusions derived from the AAP−d-IPH structure likely led to an incorrect assignment for the role of the
second metal ion in the peptide hydrolysis reaction catalyzed by AAP (15, 27).
LPA provides an excellent mimic for the transition state in the putative reaction pathway of peptide hydrolysis
particularly because it has the correct l-configuration for peptide hydrolysis. Therefore, upon nucleophilic attack
at the carbonyl sp2 carbon atom of a peptide bond by an active site hydroxyl, the resultant sp3 carbon-containing
transition state would be similar in structure to the R-PO3 group of LPA. The fact that no bridging water molecule
is present in the AAP−LPA structure and that Glu151 forms a hydrogen bond with the O3 atom of LPA (3.0 Å) is
consistent with O3 being the hydroxyl oxygen atom of the nucleophile. The role of Glu151 is likely to assist in the
deprotonation of the terminal water molecule to the nucleophilic hydroxo moiety, a role similar to that
proposed for Glu270 in carboxypeptidase A (59). The coordination of O3 to Zn2 suggests that after nucleophilic
attack by the hydroxide ion, the resulting transition state is stabilized by the additional binding interactions via
the second metal ion in the dinuclear active site of AAP. At this point in the mechanism, the metal-bound
hydroxide can attack the activated scissile carbonyl carbon of the peptide substrate, forming a gem-diolate
transition-state intermediate complex that is stabilized by coordination of both oxygen atoms to the dizinc(II)
center, consistent with the [ZnZn(AAP)]−LPA structure. Glu151 likely provides an additional proton to the
nucleophilic oxygen atom, returning it to its ionized state. Product formation would then be predicted to be the
rate-limiting step, which is consistent with recent thermodynamic results (27). Finally, the dizinc(II) cluster
releases the cleaved peptides and adds a water molecule that bridges the two metal ions. These data suggest
that the second metal ion in the dinuclear active site acts to stabilize the transition state of hydrolysis, since a
significantly greater number of binding interactions occur in the transition state than in the substrate binding
step. Thus, both metal ions are required for the full enzymatic activity of AAP, but their individual roles appear
to differ markedly.
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